Oxford Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-29,657
| Closed | -$3.21M | – | 1608 |
|
|
2019
Q4 | $3.21M | Sell |
29,657
-7,349
| -20% | -$795K | 0.09% | 231 |
|
|
2019
Q3 | $3.62M | Sell |
37,006
-54,158
| -59% | -$5.3M | 0.09% | 267 |
|
|
2019
Q2 | $11.9M | Buy |
+91,164
| New | +$11.9M | 0.26% | 56 |
|
|
2019
Q1 | – | Sell |
-14,660
| Closed | -$1.43M | – | 2119 |
|
|
2018
Q4 | $1.43M | Buy |
+14,660
| New | +$1.43M | 0.04% | 670 |
|
|
2018
Q3 | – | Sell |
-42,588
| Closed | -$5.28M | – | 2033 |
|
|
2018
Q2 | $5.28M | Buy |
42,588
+34,621
| +435% | +$4.29M | 0.1% | 219 |
|
|
2018
Q1 | $888K | Buy |
+7,967
| New | +$888K | 0.02% | 989 |
|
|
2017
Q4 | – | Sell |
-36,710
| Closed | -$5.15M | – | 1941 |
|
|
2017
Q3 | $5.15M | Sell |
36,710
-65,518
| -64% | -$9.19M | 0.1% | 220 |
|
|
2017
Q2 | $12.4M | Buy |
+102,228
| New | +$12.4M | 0.25% | 41 |
|
|
2015
Q1 | – | Sell |
-15,495
| Closed | -$2.91M | – | 783 |
|
|
2014
Q4 | $2.91M | Buy |
+15,495
| New | +$2.91M | 0.06% | 297 |
|
|
2013
Q3 | – | Sell |
-8,772
| Closed | -$809K | – | 946 |
|
|
2013
Q2 | $809K | Buy |
+8,772
| New | +$809K | 0.02% | 622 |
|